BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East

Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...

September 02, 2022 | News

Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...

September 01, 2022 | News

Biocytogen Expands Partnership with Merck

Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...

August 29, 2022 | News

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi t...

August 29, 2022 | News

Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies

Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...

August 25, 2022 | News

MGI Supports the Ministry of Health of Indonesia in the Country's Breakthrough National Genome Project

Genomics science has been identified as a key part of health technology development under the six-pillar healthcare transformation strategy announced by&nb...

August 25, 2022 | News

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...

August 24, 2022 | News

Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation

Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership th...

August 19, 2022 | News

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announ...

August 17, 2022 | News

Jackson ImmunoResearch announces new range of antibodies for serology and diagnostics market

Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of pro...

August 10, 2022 | News

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...

August 09, 2022 | News

10x Genomics Reports Second Quarter 2022 Financial Results

Recent Highlights Revenue was $114.6 million for the second quarter, representing a 1% decrease over the corresponding period of 2021. Announ...

August 09, 2022 | News

Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development

Biomedical industry is an important part of Wuxi's modern industrial system construction during the 14th Five-Year Plan(2021-2025) period. Its scale topped...

August 09, 2022 | News

Biosynth Carbosynth to offer Enzyme Development following Acquisition of EUCODIS Bioscience

Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today that it has signed an agreemen...

August 08, 2022 | News

Stay Connected